All Stories

  1. Crinecerfont: emerging role in the management of congenital adrenal hyperplasia

    Article • Expert Review of Endocrinology & Metabolism, August 2026, Taylor & Francis

    Henrik Falhammar

  2. Histopathological stratification of primary aldosteronism using the CYP11B2 size ratio: first evaluation in clinical routine

    Article • Histopathology, August 2026, Wiley

    Henrik Falhammar

  3. Survival without treatment of patients with classic and nonclassic 21-hydroxylase deficiency: a multicenter retrospective cohort study

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2026, Endocrine Society

    Henrik Falhammar

  4. Psychosocial retrospective follow-up of young adults with congenital adrenal hyperplasia

    Article • European Journal of Endocrinology, July 2026, Oxford University Press (OUP)

    Henrik Falhammar

  5. Psychiatric morbidity following liothyronine exposure in autoimmune hypothyroidism: a Swedish nationwide cohort study

    Article • Journal of the Endocrine Society, May 2026, Endocrine Society

    Henrik Falhammar

  6. The association of antidepressants with hyponatremia - preventable side-effect?

    Article • European Journal of Endocrinology, January 2026, Oxford University Press (OUP)

    Henrik Falhammar

  7. Mild Autonomous Cortisol Secretion and Psychiatric Morbidity in Patients with Adrenal Tumours: A Population-Based Retrospective Cohort Study

    Article • January 2026, Elsevier

    Henrik Falhammar

  8. Emerging methods for subtype differentiation in primary aldosteronism

    Article • Journal of Internal Medicine, December 2025, Wiley

    Henrik Falhammar

  9. Letter to the Editor from Hedberg et al: Treatment of Hypothyroidism That Contains Liothyronine Is Associated with Reduced Risk of Dementia and Mortality

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2025, Endocrine Society

    Henrik Falhammar

  10. Neurologic and psychiatric disorders following correction of profound hyponatremia - A cohort study

    Article • European Journal of Internal Medicine, October 2025, Elsevier

    Henrik Falhammar

  11. Psychiatric and Sleep Disorders in Patients With Nonfunctional Adrenal Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2025, Endocrine Society

    Henrik Falhammar

  12. Hyponatremia and mortality: Marker of disease or modifiable risk? Rethinking causality in large-scale observational research. Authors’ reply

    Article • European Journal of Internal Medicine, September 2025, Elsevier

    Henrik Falhammar

  13. Mortality and causes of death in patients hospitalized with hyponatremia – a propensity matched cohort study

    Article • European Journal of Internal Medicine, August 2025, Elsevier

    Henrik Falhammar

  14. Improving diagnosis in primary aldosteronism using HISTALDO and nodule size metrics

    Article • European Journal of Endocrinology, July 2025, Oxford University Press (OUP)

    Henrik Falhammar

  15. Dysmagnesemia in the ICU: A Comparative Analysis of Ionized and Total Magnesium Levels and Their Clinical Associations

    Article • Metabolites, July 2025, MDPI AG

    Abdullah M Al Alawi, Henrik Falhammar

  16. Differences in Clinical Presentation Between Pheochromocytomas and Paragangliomas

    Article • Clinical Endocrinology, July 2025, Wiley

    Henrik Falhammar

  17. Drug-induced hyponatremia in clinical care

    Article • European Journal of Internal Medicine, July 2025, Elsevier

    Henrik Falhammar

  18. The association of selective serotonin reuptake inhibitors and venlafaxine with profound hyponatremia

    Article • European Journal of Endocrinology, June 2025, Oxford University Press (OUP)

    Henrik Falhammar

  19. The Role of Cortisol Secretion in Pheochromocytomas and Paragangliomas: Clinical and Perioperative Implications

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2025, Endocrine Society

    Henrik Falhammar

  20. Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2025, Endocrine Society

    Henrik Falhammar

  21. Survival probabilities in patients with ectopic Cushing's syndrome—a systematic review and a single-arm meta-analysis

    Article • European Journal of Endocrinology, May 2025, Oxford University Press (OUP)

    Henrik Falhammar

  22. Cytological Assessment of Adrenal Tumours: Insights From 22‐Years Single Centre Experience

    Article • Clinical Endocrinology, April 2025, Wiley

    Henrik Falhammar

  23. Risk of Dementia in Non‐Overtly Functional Adrenal Tumours (NOFAT)—Reply

    Article • Clinical Endocrinology, March 2025, Wiley

    Henrik Falhammar

  24. Adrenal Tumors in Children and Adolescents in Sweden: A Register-Based Study Covering 15 Years

    Article • Journal of the Endocrine Society, March 2025, Endocrine Society

    Henrik Falhammar

  25. Validation of ICD-10 codes used to identify the main reason for hospitalization due to hyponatremia in Sweden

    Article • PLOS One, February 2025, PLOS

    PhD Jan Calissendorff, Henrik Falhammar

  26. Recent advances in treatments for congenital adrenal hyperplasia

    Article • Nature Reviews Endocrinology, February 2025, Springer Science + Business Media

    Henrik Falhammar

  27. Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications

    Article • Journal of the Endocrine Society, January 2025, Endocrine Society

    Henrik Falhammar

  28. Challenges in Adolescent and Adult Males With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2025, Endocrine Society

    Henrik Falhammar

  29. Offloading Interventions for the Management of Charcot Neuroarthropathy in Diabetes

    Article • Foot & Ankle Orthopaedics, January 2025, SAGE Publications

    Henrik Falhammar

  30. Prevalence and Incidence of Dementia in Patients With Non‐Overtly Functional Adrenal Tumours

    Article • Clinical Endocrinology, December 2024, Wiley

    Henrik Falhammar

  31. Renal pseudohypoaldosteronism type 1—an adult case series including a novel gene variant

    Article • Endocrine, November 2024, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  32. Adrenocortical tumors and hereditary syndromes

    Article • Expert Review of Endocrinology & Metabolism, November 2024, Taylor & Francis

    Henrik Falhammar

  33. Adrenal Crisis and Adrenal Insufficiency Admissions in Patients 30–59 Years: Contribution of Psychosocial Factors

    Article • Clinical Endocrinology, November 2024, Wiley

    Henrik Falhammar

  34. 17α-Hydroxylase/17,20-lyase Deficiency (17-OHD): A Meta-analysis of Reported Cases

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2024, Endocrine Society

    Henrik Falhammar

  35. Women’s response regarding timing of genital surgery in congenital adrenal hyperplasia

    Article • Endocrine, October 2024, Springer Science + Business Media

    Henrik Falhammar

  36. The Association of Outdoor Temperature with Severe Hyponatremia

    Article • Journal of the American Society of Nephrology, October 2024, Wolters Kluwer Health

    Issa Issa, Henrik Falhammar

  37. Cardiometabolic Aspects of Congenital Adrenal Hyperplasia

    Article • Endocrine Reviews, September 2024, Endocrine Society

    Henrik Falhammar

  38. The Incidence of Cancers in Patients With Nonfunctional Adrenal Tumors: A Swedish Population-Based National Cohort Study

    Article • Journal of the Endocrine Society, August 2024, Endocrine Society

    Henrik Falhammar

  39. Prevalence of Dysmagnesemia among Patients with Diabetes Mellitus and the Associated Health Outcomes: A Cross-Sectional Study

    Article • Biomedicines, May 2024, MDPI AG

    Henrik Falhammar, Abdullah M Al Alawi

  40. Memory in female adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

    Article • Endocrine, May 2024, Springer Science + Business Media

    Henrik Falhammar

  41. Population data evidence of interdependence of the limbs of hormonal feedback loops

    Article • Journal of Endocrinology, May 2024, Bioscientifica

    Professor Rudolf Hoermann, Henrik Falhammar

  42. Adrenal tumors in patients with neuroendocrine neoplasms

    Article • Endocrine, April 2024, Springer Science + Business Media

    Henrik Falhammar

  43. A clinical perspective on ectopic Cushing’s syndrome

    Article • Trends in Endocrinology and Metabolism, April 2024, Elsevier

    Henrik Falhammar

  44. Surgical outcome after thyroidectomy due to Graves’ disease and Lugol iodine treatment: a retrospective register-based cohort study

    Article • Endocrine, February 2024, Springer Science + Business Media

    Henrik Falhammar, PhD Jan Calissendorff

  45. Re: “Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status” by Van Uytfanghe et al.

    Article • Thyroid, November 2023, Mary Ann Liebert Inc

    Professor Rudolf Hoermann, Henrik Falhammar

  46. Lung Carcinoids: A Comprehensive Review for Clinicians

    Article • Cancers, November 2023, MDPI AG

    Henrik Falhammar

  47. Increased Prevalence of Accidents and Injuries in Congenital Adrenal Hyperplasia: A Population-based Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2023, Endocrine Society

    Henrik Falhammar

  48. Incidence of Dysmagnesemia among Medically Hospitalized Patients and Associated Clinical Characteristics: A Prospective Cohort Study

    Article • International Journal of Endocrinology, October 2023, Hindawi Publishing Corporation

    Henrik Falhammar, Abdullah M Al Alawi

  49. The Stability of Analytes of Ionized Magnesium Concentration and Its Reference Range in Healthy Volunteers

    Article • Biomedicines, September 2023, MDPI AG

    Henrik Falhammar, Abdullah M Al Alawi

  50. Approach to the Patient: Reninoma

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2023, Endocrine Society

    Henrik Falhammar

  51. Hypermagnesemia in Clinical Practice

    Article • Medicina, June 2023, MDPI AG

    Henrik Falhammar, Abdullah M Al Alawi

  52. Congenital adrenal hyperplasia in the Nordic countries – a potential base for long-term outcome studies

    Article • The Lancet Regional Health - Europe, May 2023, Elsevier

    Henrik Falhammar

  53. Adrenal cysts: an emerging condition

    Article • Nature Reviews Endocrinology, April 2023, Springer Science + Business Media

    Henrik Falhammar, PhD Jan Calissendorff

  54. Response to Letter to the Editor From Yu: “Adrenal Medullary Hyperplasia: A Systematic Review and Meta-analysis”

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2023, Endocrine Society

    Henrik Falhammar

  55. Transition Readiness in Adolescents and Young Adults Living With Congenital Adrenal Hyperplasia

    Article • Endocrine Practice, April 2023, Elsevier

    Henrik Falhammar

  56. Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2023, Endocrine Society

    Henrik Falhammar

  57. Adrenal Medullary Hyperplasia: A Systematic Review and Meta-analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2023, Endocrine Society

    Henrik Falhammar

  58. Tuberculosis of Adrenal Glands—A Population-based Case-control Study

    Article • Journal of the Endocrine Society, March 2023, Endocrine Society

    Henrik Falhammar

  59. Corticosteroid-binding globulin (CBG): spatiotemporal distribution of cortisol in sepsis

    Article • Trends in Endocrinology and Metabolism, March 2023, Elsevier

    Henrik Falhammar

  60. Hypoglycemia after exposure of diclofenac medication

    Article • Endocrine, November 2022, Springer Science + Business Media

    Henrik Falhammar

  61. Congenital adrenal hyperplasia in patients with adrenal tumors: a population-based case–control study

    Article • Journal of Endocrinological Investigation, October 2022, Springer Science + Business Media

    Henrik Falhammar

  62. Physiological linkage of thyroid and pituitary sensitivities

    Article • Endocrine, September 2022, Springer Science + Business Media

    Professor Rudolf Hoermann, Henrik Falhammar

  63. Long-Term Outcomes of Congenital Adrenal Hyperplasia

    Article • Endocrinology and Metabolism, August 2022, Korean Endocrine Society (KAMJE)

    Henrik Falhammar

  64. Long-Term Results of Surgical Treatment and Patient-Reported Outcomes in Congenital Adrenal Hyperplasia—A Multicenter European Registry Study

    Article • Journal of Clinical Medicine, August 2022, MDPI AG

    Henrik Falhammar

  65. Ambulatory fludrocortisone suppression test in the diagnosis of primary aldosteronism: Safety, accuracy and cost‐effectiveness

    Article • Clinical Endocrinology, July 2022, Wiley

    Henrik Falhammar

  66. Adrenal crises in adolescents and young adults

    Article • Endocrine, May 2022, Springer Science + Business Media

    Henrik Falhammar

  67. Prevalence and incidence of diabetes among Aboriginal people in remote communities of the Northern Territory, Australia: a retrospective, longitudinal data-linkage study

    Article • BMJ Open, May 2022, BMJ

    Henrik Falhammar

  68. Adrenal trauma experience at a major tertiary centre in Sweden: Clinical and radiological findings

    Article • Clinical Endocrinology, February 2022, Wiley

    Henrik Falhammar

  69. Current and Future Burdens of Heat-Related Hyponatremia: A Nationwide Register–Based Study

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2022, Endocrine Society

    Henrik Falhammar

  70. Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance

    Article • Cancers, February 2022, MDPI AG

    Henrik Falhammar, PhD Jan Calissendorff

  71. Current and Novel Treatment Strategies in Children with Congenital Adrenal Hyperplasia

    Article • Hormone Research in Paediatrics, January 2022, Karger Publishers

    Henrik Falhammar

  72. The impact of adherence and therapy regimens on quality of life in patients with congenital adrenal hyperplasia

    Article • Clinical Endocrinology, January 2022, Wiley

    Henrik Falhammar

  73. Institutional characterisation of water clear cell parathyroid adenoma: a rare entity often unrecognised by TC-99m-sestamibi scintigraphy

    Article • Pathology, December 2021, Elsevier

    Henrik Falhammar

  74. Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2021, Endocrine Society

    Henrik Falhammar

  75. Thyroid testing paradigm switch from thyrotropin to thyroid hormones—Future directions and opportunities in clinical medicine and research

    Article • Endocrine, August 2021, Springer Science + Business Media

    Henrik Falhammar

  76. Metastasis to the thyroid gland: Characterization and survival of an institutional series spanning 28 years

    Article • European Journal of Surgical Oncology, June 2021, Elsevier

    Henrik Falhammar, PhD Jan Calissendorff

  77. Non‐thiazide diuretics and hospitalization due to hyponatraemia: A population‐based case‐control study

    Article • Clinical Endocrinology, May 2021, Wiley

    Henrik Falhammar

  78. Corrigendum to “Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy”

    Article • Journal of Diabetes Research, May 2021, Wiley

    Henrik Falhammar

  79. Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management

    Article • Endocrine Reviews, May 2021, Endocrine Society

    Henrik Falhammar, Dr Phyllis W Speiser

  80. Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia

    Article • Journal of Psychopharmacology, April 2021, SAGE Publications

    Henrik Falhammar

  81. Top End Pulmonary Hypertension Study: Understanding Epidemiology, Therapeutic Gaps and Prognosis in Remote Australian Setting

    Article • Heart Lung and Circulation, April 2021, Elsevier

    Henrik Falhammar

  82. First insights into the genetics of 21‐hydroxylase deficiency in the Roma population

    Article • Clinical Endocrinology, March 2021, Wiley

    Henrik Falhammar

  83. Metastatic Pheochromocytomas and Abdominal Paragangliomas

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2021, Endocrine Society

    Henrik Falhammar

  84. Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self‐management

    Article • Clinical Endocrinology, January 2021, Wiley

    Henrik Falhammar

  85. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

    Article • Hormone Research in Paediatrics, January 2021, Karger Publishers

    Henrik Falhammar

  86. Authors' Response to Hennessey re: DOI: 10.1089/thy.2019.0535

    Article • Thyroid, December 2020, Mary Ann Liebert Inc

    Henrik Falhammar

  87. Clinical Parameters Are More Likely to Be Associated with Thyroid Hormone Levels than with Thyrotropin Levels: A Systematic Review and Meta-Analysis

    Article • Thyroid, December 2020, Mary Ann Liebert Inc

    Henrik Falhammar

  88. 11C-Metomidate PET/CT Detected Multiple Ectopic Adrenal Rest Tumors in a Woman With Congenital Adrenal Hyperplasia

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2020, Endocrine Society

    Henrik Falhammar

  89. Correction to: Inverse association between glucose-lowering medications and severe hyponatremia: a Swedish population-based case-control study

    Article • Endocrine, November 2020, Springer Science + Business Media

    Henrik Falhammar

  90. Reproductive and Perinatal Outcomes in Women with Congenital Adrenal Hyperplasia: A Population-based Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2020, Endocrine Society

    Henrik Falhammar

  91. Prevalence and Characteristics of Adrenal Tumors and Myelolipomas in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

    Article • Endocrine Practice, November 2020, Elsevier

    Henrik Falhammar

  92. Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms

    Article • Frontiers in Endocrinology, October 2020, Frontiers

    Henrik Falhammar

  93. Obstructive sleep apnoea and adherence to continuous positive airway therapy among Australian women

    Article • Internal Medicine Journal, October 2020, Wiley

    Dr Dimitar Sajkov, Henrik Falhammar

  94. Top End Pulmonary Hypertension Study: Understanding Epidemiology, Therapeutic Gaps and Prognosis in Remote Australian Setting

    Article • September 2020, Cold Spring Harbor Laboratory Press

    Henrik Falhammar

  95. Predictors of normalized HbA1c after gastric bypass surgery in subjects with abnormal glucose levels, a 2-year follow-up study

    Article • Scientific Reports, September 2020, Springer Science + Business Media

    Henrik Falhammar

  96. Lower extremity amputations and long-term outcomes in diabetic foot ulcers: A systematic review

    Article • World Journal of Diabetes, September 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Henrik Falhammar

  97. Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

    Article • International Journal of Neonatal Screening, August 2020, MDPI AG

    Henrik Falhammar

  98. Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission

    Article • BMC Gastroenterology, August 2020, Springer Science + Business Media

    Henrik Falhammar

  99. The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients

    Article • International Journal of Neonatal Screening, August 2020, MDPI AG

    Henrik Falhammar

  100. Trends in the incidence of adrenal incidentaloma diagnosed by CT abdomen in 2002 and 2015: Preliminary data from a retrospective study in regional sweden

    Article • Endocrine Abstracts, August 2020, Bioscientifica

    Henrik Falhammar

  101. Diabetes during pregnancy and birthweight trends among Aboriginal and non-Aboriginal people in the Northern Territory of Australia over 30 years

    Article • The Lancet Regional Health - Western Pacific, August 2020, Elsevier

    Henrik Falhammar

  102. Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

    Article • Frontiers in Endocrinology, July 2020, Frontiers

    Henrik Falhammar

  103. Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas

    Article • Journal of Clinical Medicine, July 2020, MDPI AG

    Henrik Falhammar

  104. Ectopic ACTH- and/or CRH-Producing Pheochromocytomas

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2020, Endocrine Society

    Henrik Falhammar

  105. Reduced risk for hospitalization due to hyponatraemia in lithium treated patients: A Swedish population-based case–control study

    Article • Journal of Psychopharmacology, July 2020, SAGE Publications

    Henrik Falhammar

  106. Riedel Thyroiditis

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2020, Endocrine Society

    Henrik Falhammar

  107. Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes

    Article • Scientific Reports, July 2020, Springer Science + Business Media

    Henrik Falhammar

  108. Adrenal crises in older patients

    Article • The Lancet Diabetes & Endocrinology, July 2020, Elsevier

    Henrik Falhammar

  109. Lactation Ketoacidosis: A Systematic Review of Case Reports

    Article • Medicina, June 2020, MDPI AG

    Abdullah M Al Alawi, Henrik Falhammar

  110. Genetic and Biological Effects of ICAM-1 E469K Polymorphism in Diabetic Kidney Disease

    Article • Journal of Diabetes Research, June 2020, Hindawi Publishing Corporation

    Henrik Falhammar

  111. The effect of patient‐managed stress dosing on electrolytes and blood pressure in acute illness in children with adrenal insufficiency

    Article • Clinical Endocrinology, June 2020, Wiley

    Henrik Falhammar

  112. Multiple cutaneous lesions and pulmonary cysts

    Article • European Journal of Internal Medicine, June 2020, Elsevier

    Henrik Falhammar

  113. Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience from a Multicenter Survey

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2020, Endocrine Society

    Henrik Falhammar

  114. Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

    Article • Endocrine, May 2020, Springer Science + Business Media

    Henrik Falhammar

  115. Mucormycosis in a 40-year-old woman with diabetic ketoacidosis

    Article • Canadian Medical Association Journal, April 2020, Canadian Medical Association (CMA)

    Henrik Falhammar

  116. Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population–Based Case–Control Study

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2020, Endocrine Society

    Henrik Falhammar

  117. MON-183 Adrenal Androgen Control and Steroidal Side Effects in Adolescents and Adults with Congenital Adrenal Hyperplasia Treated with Glucocorticoids

    Article • Journal of the Endocrine Society, April 2020, Endocrine Society

    Henrik Falhammar

  118. OR25-05 Increased Overall Mortality and Cardiovascular Morbidity in Patients with Adrenal Incidentalomas and Autonomous Cortisol Secretion: Results of the ENS@T NAPACA-Outcome Study

    Article • Journal of the Endocrine Society, April 2020, Endocrine Society

    Henrik Falhammar

  119. Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years

    Article • Endocrine Pathology, March 2020, Springer Science + Business Media

    Henrik Falhammar

  120. Sexual Orientation in Individuals With Congenital Adrenal Hyperplasia: A Systematic Review

    Article • Frontiers in Behavioral Neuroscience, March 2020, Frontiers

    Henrik Falhammar

  121. Clinical features, complications, and outcomes of exogenous and endogenous catecholamine‐triggered Takotsubo syndrome: A systematic review and meta‐analysis of 156 published cases

    Article • Clinical Cardiology, March 2020, Wiley

    Henrik Falhammar

  122. Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd‐LIFE study

    Article • Clinical Endocrinology, January 2020, Wiley

    Henrik Falhammar

  123. To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence?

    Article • Medicina, January 2020, MDPI AG

    Henrik Falhammar, PhD Jan Calissendorff

  124. All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study

    Article • BMJ Open, January 2020, BMJ

    Henrik Falhammar

  125. Stumbling broke the spleen and unveiled pheochromocytoma, which in turn broke the heart

    Article • Endocrine, December 2019, Springer Science + Business Media

    Henrik Falhammar

  126. Inverse association between glucose-lowering medications and severe hyponatremia: a Swedish population-based case-control study

    Article • Endocrine, December 2019, Springer Science + Business Media

    Henrik Falhammar

  127. Lactation Ketoacidosis: A case series

    Article • Sultan Qaboos University Medical Journal, December 2019, Sultan Qaboos University Medical Journal

    Abdullah M Al Alawi, Henrik Falhammar

  128. P450 Oxidoreductase Deficiency: A Systematic Review and Meta-analysis of Genotypes, Phenotypes, and Their Relationships

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2019, Endocrine Society

    Henrik Falhammar

  129. Acute suppurative thyroiditis with thyroid abscess in adults: clinical presentation, treatment and outcomes

    Article • BMC Endocrine Disorders, December 2019, Springer Science + Business Media

    Henrik Falhammar, PhD Jan Calissendorff

  130. Acute suppurative thyroiditis with thyroid abscess in adults: clinical presentation, treatment and outcomes

    Article • November 2019, Research Square

    Henrik Falhammar, PhD Jan Calissendorff

  131. Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden: A population‐based register study

    Article • Pharmacoepidemiology and Drug Safety, November 2019, Wiley

    Henrik Falhammar

  132. Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study

    Article • European Journal of Internal Medicine, November 2019, Elsevier

    Henrik Falhammar

  133. Pyogenic hepatic abscess secondary to gastric perforation caused by an ingested fish bone

    Article • The Medical Journal of Australia, October 2019, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Henrik Falhammar

  134. Acute suppurative thyroiditis with thyroid abscess in adults: clinical presentation, treatment and outcomes

    Article • September 2019, Research Square

    Henrik Falhammar, PhD Jan Calissendorff

  135. Acceptance and tolerability of 75 g Pregnancy Oral Glucose Tolerance Test in Pregnancy

    Article • September 2019, Research Square

    Henrik Falhammar

  136. Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study

    Article • Endocrine, September 2019, Springer Science + Business Media

    Henrik Falhammar

  137. Adrenal Crisis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2019, New England Journal of Medicine (NEJM/MMS)

    Henrik Falhammar

  138. Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome

    Article • Endocrine, August 2019, Springer Science + Business Media

    Henrik Falhammar

  139. Carriers of a Classic CYP21A2 Mutation Have Reduced Mortality: A Population-Based National Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2019, Endocrine Society

    Henrik Falhammar

  140. Amputations in patients with diabetic foot ulcer: a retrospective study from a single centre in the Northern Territory of Australia

    Article • Australian and New Zealand Journal of Surgery, July 2019, Wiley

    Henrik Falhammar

  141. Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma

    Article • Journal of the Endocrine Society, June 2019, Endocrine Society

    Henrik Falhammar

  142. Population data provide evidence against the presence of a set point for hemoglobin levels or tissue oxygen delivery

    Article • Physiological Reports, June 2019, Wiley

    Henrik Falhammar

  143. Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy

    Article • Journal of Diabetes Research, May 2019, Hindawi Publishing Corporation

    Dr Xiaowei Zheng, Henrik Falhammar, Harvest Gu

  144. Management and outcome of pregnancies in women with adrenal insufficiency: experience from a retrospective European study

    Article • Endocrine Abstracts, May 2019, Bioscientifica

    Henrik Falhammar

  145. Prevalence of autonomous cortisol secretion as defined in ESE guidelines in a Swedish cohort of patients diagnosed with adrenal incidentaloma: A prospective study in regional Sweden

    Article • Endocrine Abstracts, May 2019, Bioscientifica

    Henrik Falhammar

  146. Adrenal insufficiency due to bilateral adrenal metastases – A systematic review and meta-analysis

    Article • Heliyon, May 2019, Elsevier

    Henrik Falhammar

  147. Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

    Article • Journal of the Endocrine Society, April 2019, Endocrine Society

    Henrik Falhammar

  148. New cost-effective pleural procedure training: manikin-based model to increase the confidence and competency in trainee medical officers

    Article • Postgraduate Medical Journal, April 2019, BMJ

    Dr Dimitar Sajkov, Henrik Falhammar

  149. Increased Risk of Autoimmune Disorders in 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study

    Article • Journal of the Endocrine Society, April 2019, Endocrine Society

    Henrik Falhammar

  150. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency

    Article • European Journal of Endocrinology, March 2019, Oxford University Press (OUP)

    Henrik Falhammar

  151. Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency

    Article • Endocrine, February 2019, Springer Science + Business Media

    Abdullah M Al Alawi, Henrik Falhammar

  152. Antipsychotics and severe hyponatremia: A Swedish population–based case–control study

    Article • European Journal of Internal Medicine, February 2019, Elsevier

    Henrik Falhammar

  153. Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia

    Article • BMC Endocrine Disorders, January 2019, Springer Science + Business Media

    Henrik Falhammar

  154. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population–based case–control study

    Article • European Journal of Internal Medicine, January 2019, Elsevier

    Henrik Falhammar

  155. 11β-Hydroxylase Deficiency

    Article • January 2019, Elsevier

    Henrik Falhammar

  156. Epidemiology of Pulmonary Hypertension at the Top End of Australia

    Article • Heart Lung and Circulation, January 2019, Elsevier

    Henrik Falhammar

  157. Variations in the management of acute illness in children with congenital adrenal hyperplasia: An audit of three paediatric hospitals

    Article • Clinical Endocrinology, September 2018, Wiley

    Henrik Falhammar

  158. Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center

    Article • Endocrine, September 2018, Springer Science + Business Media

    Henrik Falhammar

  159. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review

    Article • Endocrine, August 2018, Springer Science + Business Media

    Henrik Falhammar

  160. A Sickening Tale

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2018, New England Journal of Medicine (NEJM/MMS)

    Henrik Falhammar

  161. Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population–based case–control study

    Article • Seizure, July 2018, Elsevier

    PhD Jan Calissendorff, Henrik Falhammar

  162. Lactation ketoacidosis: case presentation and literature review

    Article • BMJ Case Reports, May 2018, BMJ

    Abdullah M Al Alawi, Henrik Falhammar

  163. Extensive Bilateral Adrenal Rest Testicular Tumors in a Patient With 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency

    Article • Journal of the Endocrine Society, May 2018, Endocrine Society

    Henrik Falhammar

  164. Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2018, Endocrine Society

    Henrik Falhammar

  165. Two rare forms of congenital adrenal hyperplasia, 11β hydroxylase deficiency and 17-hydroxylase/17,20-lyase deficiency, presenting with novel mutations

    Article • HORMONES, March 2018, Springer Science + Business Media

    Henrik Falhammar

  166. Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study

    Article • Endocrine Connections, February 2018, Bioscientifica

    Henrik Falhammar

  167. Successful fertility outcome in a woman with 17ɑ-hydroxylase deficiency

    Article • Clinical Endocrinology, January 2018, Wiley

    Henrik Falhammar

  168. Riedel’s thyroiditis: clinical presentation, treatment and outcomes

    Article • Endocrine, January 2018, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  169. Gonadal function in adult male patients with congenital adrenal hyperplasia

    Article • European Journal of Endocrinology, January 2018, Bioscientifica

    Julia Rohayem, Henrik Falhammar

  170. Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia

    Article • The American Journal of Medicine, January 2018, Elsevier

    PhD Jan Calissendorff, Henrik Falhammar

  171. Magnesium and Human Health: Perspectives and Research Directions

    Article • International Journal of Endocrinology, January 2018, Hindawi Publishing Corporation

    Henrik Falhammar, Abdullah M Al Alawi

  172. Adrenal Crises in Children: Perspectives and Research Directions

    Article • Hormone Research in Paediatrics, January 2018, Karger Publishers

    Henrik Falhammar

  173. Skeletal fragility induced by overtreatment of adrenal insufficiency

    Article • Endocrine, December 2017, Springer Science + Business Media

    Henrik Falhammar

  174. Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center

    Article • Endocrine Connections, December 2017, Bioscientifica

    PhD Jan Calissendorff, Henrik Falhammar

  175. Trends in surgery, hospital admissions and imaging for pituitary adenomas in Australia

    Article • Endocrine, November 2017, Springer Science + Business Media

    Henrik Falhammar

  176. Lugol’s solution and other iodide preparations: perspectives and research directions in Graves’ disease

    Article • Endocrine, October 2017, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  177. Pleural Lipomatosis Masquerading as Pleural Mass With Effusion

    Article • CHEST Journal, October 2017, Elsevier

    sumit mehra, Henrik Falhammar

  178. Cost-effectiveness of stroke care in Aboriginal and non-Aboriginal patients: an observational cohort study in the Northern Territory of Australia

    Article • BMJ Open, October 2017, BMJ

    Henrik Falhammar

  179. Reduced Frequency of Biological and Increased Frequency of Adopted Children in Males With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2017, Endocrine Society

    Henrik Falhammar

  180. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center

    Article • Endocrine, September 2017, Springer Science + Business Media

    Henrik Falhammar

  181. Swyer-James-MacLeod syndrome-a rare diagnosis presented through two adult patients

    Article • Respirology Case Reports, June 2017, Wiley

    sumit mehra, Henrik Falhammar

  182. Rescue pre-operative treatment with Lugol’s solution in uncontrolled Graves’ disease

    Article • Endocrine Connections, March 2017, Bioscientifica

    PhD Jan Calissendorff, Henrik Falhammar

  183. Hospitalisation in Children with Adrenal Insufficiency and Hypopituitarism: Is There a Differential Burden between Boys and Girls and between Age Groups?

    Article • Hormone Research in Paediatrics, January 2017, Karger Publishers

    Henrik Falhammar

  184. Adrenal crises: perspectives and research directions

    Article • Endocrine, December 2016, Springer Science + Business Media

    Henrik Falhammar

  185. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency

    Article • Endocrine, December 2016, Springer Science + Business Media

    Henrik Falhammar

  186. Are carriers ofCYP21A2mutations less vulnerable to psychological stress? A population-based national cohort study

    Article • Clinical Endocrinology, October 2016, Wiley

    Henrik Falhammar

  187. Frequency of Cushing’s syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center

    Article • Endocrine, October 2016, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  188. Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists

    Article • Endocrine, September 2016, Springer Science + Business Media

    Henrik Falhammar

  189. A 42-year-old man presented with adrenal incidentaloma due to non-classic congenital adrenal hyperplasia with a novelCYP21A2mutation

    Article • Internal Medicine Journal, September 2016, Wiley

    Henrik Falhammar

  190. Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency Presenting as Adrenal Incidentaloma: A Systematic Review and Meta-Analysis

    Article • Endocrine Practice, June 2016, Elsevier

    Henrik Falhammar

  191. Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids – experience from a single centre spanning three decades

    Article • BMC Endocrine Disorders, March 2016, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  192. Relationship between depression and diabetes in pregnancy: A systematic review

    Article • World Journal of Diabetes, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Henrik Falhammar

  193. Hospital Admission Patterns in Children with CAH: Admission Rates and Adrenal Crises Decline with Age

    Article • International Journal of Endocrinology, January 2016, Hindawi Publishing Corporation

    Henrik Falhammar

  194. Congenital Adrenal Hyperplasia, Polycystic Ovary Syndrome and criminal behavior: A Swedish population based study

    Article • Psychiatry Research, October 2015, Elsevier

    Henrik Falhammar

  195. Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: A total population study

    Article • Psychoneuroendocrinology, October 2015, Elsevier

    Henrik Falhammar

  196. Biochemical and genetic diagnosis of 21-hydroxylase deficiency

    Article • Endocrine, September 2015, Springer Science + Business Media

    Henrik Falhammar

  197. Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2015, Endocrine Society

    Henrik Falhammar

  198. Clinical Outcomes in Adrenal Incidentaloma: Experience From one Center

    Article • Endocrine Practice, August 2015, Elsevier

    Henrik Falhammar

  199. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome

    Article • Endocrine, June 2015, Springer Science + Business Media

    Henrik Falhammar

  200. Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study

    Article • BMC Endocrine Disorders, February 2015, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  201. Genetic studies of body mass index yield new insights for obesity biology

    Article • Nature, February 2015, Nature

    Dr Cristina Menni, Professor Dorret I Boomsma, Prof Alexander P Maxwell, Jari Lahti, Henrik Falhammar

  202. New genetic loci link adipose and insulin biology to body fat distribution

    Article • Nature, February 2015, Nature

    Dr Cristina Menni, Prof Alexander P Maxwell, Jari Lahti, Giovanni Veronesi, Henrik Falhammar

  203. Pregnancy and neonatal outcomes in Indigenous Australians with diabetes in pregnancy

    Article • World Journal of Diabetes, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Henrik Falhammar

  204. Increased Mortality in Patients With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2014, Endocrine Society

    Henrik Falhammar

  205. Ileal neuroendocrine tumors and heart: not only valvular consequences

    Article • Endocrine, October 2014, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  206. GP4-3: Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in diabetes and diabetic nephropathy

    Article • Growth Hormone & IGF Research, October 2014, Elsevier

    Henrik Falhammar

  207. Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy

    Article • Clinical Epigenetics, May 2014, Springer Science + Business Media

    Henrik Falhammar

  208. Suboptimal Psychosocial Outcomes in Patients With Congenital Adrenal Hyperplasia: Epidemiological Studies in a Nonbiased National Cohort in Sweden

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2014, Endocrine Society

    Henrik Falhammar

  209. Increased Psychiatric Morbidity in Men With Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2014, Endocrine Society

    Henrik Falhammar

  210. Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?

    Article • Endocrine, January 2014, Springer Science + Business Media

    Henrik Falhammar

  211. Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia

    Article • Endocrine, January 2014, Springer Science + Business Media

    Henrik Falhammar

  212. 68Ga-DOTA-TOC-PET/CT detects heart metastases from ileal neuroendocrine tumors

    Article • Endocrine, November 2013, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  213. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study

    Article • The Lancet Diabetes & Endocrinology, September 2013, Elsevier

    Henrik Falhammar

  214. Voice problems due to virilization in adult women with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency

    Article • Clinical Endocrinology, May 2013, Wiley

    Henrik Falhammar

  215. A threefold increase in gestational diabetes over two years: Review of screening practices and pregnancy outcomes in Indigenous women of Cape York, Australia

    Article • Australian and New Zealand Journal of Obstetrics and Gynaecology, March 2013, Wiley

    Henrik Falhammar

  216. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia

    Article • December 2012, Bioscientifica

    Henrik Falhammar

  217. Pattern of Dyslipidaemia in Subjects with Coronary Artery Disease: A Study Comparing Indigenous and non-Indigenous Australians

    Article • Heart Lung and Circulation, October 2012, Elsevier

    Henrik Falhammar

  218. New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes

    Article • PLoS Genetics, September 2012, PLOS

    PhD, Adjunct professor Aila Ahola, Prof Alexander P Maxwell, Henrik Falhammar

  219. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy

    Article • Journal of Diabetes and its Complications, September 2012, Elsevier

    Henrik Falhammar

  220. Thyrotoxic periodic paralysis: clinical and molecular aspects

    Article • Endocrine, August 2012, Springer Science + Business Media

    PhD Jan Calissendorff, Henrik Falhammar

  221. Clinical outcomes in the management of congenital adrenal hyperplasia

    Article • Endocrine, January 2012, Springer Science + Business Media

    Henrik Falhammar

  222. Anthropometry in Congenital Adrenal Hyperplasia

    Article • January 2012, Springer Science + Business Media

    Henrik Falhammar

  223. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia

    Article • December 2011, Bioscientifica

    Henrik Falhammar

  224. Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

    Article • European Journal of Endocrinology, February 2011, Oxford University Press (OUP)

    Henrik Falhammar

  225. Pattern of Dyslipidaemia in Subjects with Coronary Artery Disease: A Study Comparing Indigenous and non-Indigenous Australians

    Article • Heart Lung and Circulation, January 2011, Elsevier

    Henrik Falhammar

  226. Sexual Function and Surgical Outcome in Women with Congenital Adrenal Hyperplasia Due toCYP21A2Deficiency: Clinical Perspective and the Patients’ Perception

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2010, Endocrine Society

    Henrik Falhammar

  227. Maternal and neonatal outcomes in the Torres Strait Islands with a sixfold increase in type 2 diabetes in pregnancy over six years

    Article • Australian and New Zealand Journal of Obstetrics and Gynaecology, April 2010, Wiley

    Henrik Falhammar

  228. Gender Role Behaviour, Sexuality and Sexual Function in Women With Congenital Adrenal Hyperplasia

    Article • Journal of Pediatric Urology, April 2010, Elsevier

    Henrik Falhammar

  229. Adult case of partial trisomy 9q

    Article • BMC Medical Genetics, February 2010, Springer Science + Business Media

    Henrik Falhammar

  230. Gender Role Behavior, Sexuality, and Psychosocial Adaptation in Women with Congenital Adrenal Hyperplasia due toCYP21A2Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2009, Endocrine Society

    Henrik Falhammar

  231. Maternal and neonatal outcomes following diabetes in pregnancy in Far North Queensland, Australia

    Article • Australian and New Zealand Journal of Obstetrics and Gynaecology, July 2009, Wiley

    Henrik Falhammar

  232. Pathological gambling and hypersexuality in cabergoline‐treated prolactinoma

    Article • The Medical Journal of Australia, January 2009, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Henrik Falhammar

  233. Increased Liver Enzymes in Adult Women with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

    Article • Endocrine Journal, January 2009, Japan Endocrine Society

    Henrik Falhammar

  234. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection

    Article • Sexual Health, January 2009, CSIRO Publishing

    Henrik Falhammar

  235. Voice characteristics in women with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency

    Article • Clinical Endocrinology, December 2008, Wiley

    Henrik Falhammar

  236. Hyperpigmentation, nail dystrophy and alopecia with generalised intestinal polyposis: Cronkhite–Canada syndrome

    Article • Australasian Journal of Dermatology, October 2008, Wiley

    Henrik Falhammar

  237. Physician on call: Sweden compared with Australia

    Article • The Medical Journal of Australia, October 2008, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Henrik Falhammar

  238. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

    Article • Human Reproduction, April 2008, Oxford University Press (OUP)

    Henrik Falhammar

  239. Voice Characteristics Related to Increased Levels of Androgens in Women with Congenital Adrenal Hyperplasia (CAH)

    Article • Journal of Pediatric Urology, April 2008, Elsevier

    Henrik Falhammar

  240. Type of Mutation and Surgical Procedure Affect Long-Term Quality of Life for Women with Congenital Adrenal Hyperplasia

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2008, Endocrine Society

    Henrik Falhammar

  241. A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation

    Article • Journal of Endocrinological Investigation, February 2008, Springer Science + Business Media

    Henrik Falhammar

  242. HD3-2 Screening and follow-up for gestational diabetes in the Torres strait Islands

    Article • Diabetes Research and Clinical Practice, February 2008, Elsevier

    Henrik Falhammar

  243. Fractures and Bone Mineral Density in Adult Women with 21-Hydroxylase Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2007, Endocrine Society

    Henrik Falhammar

  244. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations

    Article • European Journal of Endocrinology, November 2007, Oxford University Press (OUP)

    Henrik Falhammar

  245. Metabolic Profile and Body Composition in Adult Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2007, Endocrine Society

    Henrik Falhammar

  246. Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy

    Article • Journal of Diabetes and its Complications, January 2007, Elsevier

    Henrik Falhammar

  247. Genetic influences of the intercellular adhesion molecule 1 (ICAM‐1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy

    Article • Diabetic Medicine, August 2006, Wiley

    Henrik Falhammar

  248. An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: Connection or coincidence?

    Article • Journal of Endocrinological Investigation, July 2005, Springer Science + Business Media

    Henrik Falhammar